AVNT — AVIENT CORP
—
NYSE ·
Materials ·
Chemicals ·
CIK 1122976 ·
Last close
$37.79
Market Cap
$3.47B
52W High
$46.33
52W Low
$26.64
ADV30
744,250
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 917,000,000 | 307,600,000 | 112,400,000 | 64,800,000 | 6,004,800,000 | 425,600,000 | 3,554,800,000 |
| Mar 2026 | 847,400,000 | 272,600,000 | 95,800,000 | 55,700,000 | 5,944,800,000 | 427,600,000 | 3,526,800,000 |
| Dec 2025 | 760,600,000 | 229,600,000 | 39,600,000 | 16,900,000 | 6,025,600,000 | 510,500,000 | 3,639,300,000 |
| Sep 2025 | 806,500,000 | 244,900,000 | 67,100,000 | 32,600,000 | 6,055,800,000 | 445,600,000 | 3,667,400,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$318,200,000
Investing CF
$-103,500,000
Financing CF
$-256,600,000
CapEx
$-113,100,000
Dividends Paid
$-99,300,000
Buybacks
—
EPS Diluted TTM
$1.72
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$1,895,600,000
Inventory
$443,000,000
Receivables
$553,500,000
ST Investments
—
EBIT TTM
$320,100,000
Pretax Income TTM
$228,800,000
Interest Exp TTM
$93,700,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,331,500,032
EBITDA
$586,800,000
Free Cash Flow
$263,787,504
Enterprise Value
$5,261,406,720
Total Cash
$425,600,000
Total Debt
$1,875,800,064
Shares Out
91,719,550
Trailing EPS
$1.85
Book Value
$26.57
ROE
7.1%
ROA
4.1%
Div Yield
2.66%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 3,260,200,000 | 203,500,000 | 81,900,000 | 6,025,600,000 | 3,639,300,000 | 2,374,200,000 | 301,600,000 |
| Dec 2024 | 3,240,400,000 | 329,300,000 | 169,500,000 | 5,811,100,000 | 3,481,500,000 | 2,313,800,000 | 256,800,000 |
| Dec 2023 | 3,142,800,000 | 196,800,000 | 75,700,000 | 5,968,500,000 | 3,630,500,000 | 2,319,200,000 | 201,600,000 |
| Dec 2022 | 3,396,900,000 | 243,300,000 | 703,100,000 | 6,085,000,000 | 3,732,200,000 | 2,334,500,000 | 398,400,000 |
TTM Snapshot
Revenues TTM
$3,281,000,000
NetIncome TTM
$157,800,000
OpCashFlow TTM
—
Assets (Latest)
$5,944,800,000
Forward EPS
$3.50
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $30.00 · spot: $37.79 · call volume: 28 · put volume: 14
Expected Move to 2026-12-18:
±$5.30
(14.02%) —
implied range
$32.49 –
$43.09
· ATM straddle on $40.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IPAR | INTERPARFUMS INC | $3.59B | $112.21 | — |
| RGC | Regencell Bioscience Holdings Ltd | $3.63B | $7.35 | — |
| CBT | CABOT CORP | $3.87B | $74.91 | — |
| SMG | SCOTTS MIRACLE-GRO CO | $2.90B | $49.86 | — |
| WDFC | WD 40 CO | $2.71B | $202.29 | — |
News headlines (Yahoo Finance, 1h cache)
Avient Sinks 7% on Sudden CEO Change as New Leader Vows to “Sharpen Execution”
2026-10-09 17:30 · Yahoo
Leadership change and unchanged forecast send Avient stock tumbling 8%
2026-10-09 14:25 · Yahoo
Avient Appoints Mike Frank as Chief Executive Officer
2026-10-09 11:00 · Yahoo
Does Avient’s Sixteenth AVNT Dividend Hike Clarify Its Capital Allocation Priorities Or Complicate Them?
2026-10-08 17:14 · Yahoo
Avient Advances Circularity by Launching Nymax FR REC Flame Retardant
2026-10-02 12:05 · Yahoo
Avient to Hold Third Quarter 2026 Conference Call
2026-10-01 20:21 · Yahoo
Avient (AVNT) Could Be 12% Undervalued After Its Zacks Rank Upgrade
2026-10-01 20:08 · Yahoo
3 Stocks in Focus That Hiked Dividends Amid Ongoing Market Volatility
2026-10-09 13:11 · Yahoo
BASF Expands Ultradur Portfolio With Recycled PET Grades
2026-10-07 13:15 · Yahoo
Here's Why You Should Hold Onto Ingevity Stock for Now
2026-10-07 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.